ACA

NEUTRALM&A

Arcosa, Inc.

2026-08-27

Price

$145.49

+0.16%

This is the 2026-08-27 snapshot — the signals and analysis for ACA as of this single trading day.

View full ACA research hub →

Score9.5Priority

Signals6/8 DNA0/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume0.8xvs 20d avg

Analysis

Arcosa's (ACA) exceptionally low 2.8% realized volatility and 'QUIET_STORM' technical signals are the direct result of its pending $8.5 billion all-cash acquisition by CRH. The stock is no longer trading on fundamental earnings or macro beta, but is instead functioning as a pure merger arbitrage vehicle pinned near the deal price. The RISK_ON macro regime and virtually non-existent credit stress (HY OAS at 0.80%) provide high conviction that financing risks are neutralized, leaving the stock to quietly absorb institutional flow pending regulatory approvals.

Fired Signals

ALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSMARKET LEADERPERFECT STACK

Key Takeaways

Actionable Thesis: ACA is trading as a pure merger arbitrage play following the definitive all-cash acquisition agreement with CRH, rendering standard fundamental drivers obsolete.
Key Risk: The primary risk is regulatory pushback or antitrust concerns that could delay or terminate the acquisition, which would collapse the stock back to pre-deal valuations.
What to Watch: Monitor the deal spread and the $144.73 support level; any break below this signals rising market skepticism regarding the deal's successful close.

← Back to 2026-08-27 View Full ACA History →Yahoo Finance &nearr;